| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.1B | $1.6B | $1.4B | $1.2B | $1.2B | $4.7B |
| Cost of Revenue | $2.2B | $2.6B | $2.7B | $3.5B | $2.9B | $2.6B | $2.5B | $2.6B |
| Gross Profit | $0.4B | $0.5B | $0.4B | $0.7B | $0.6B | $0.5B | $0.6B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.6B | $0.7B | $0.8B | $0.7B | $0.7B | $0.8B | $0.9B |
| Operating Income | $-1.4B | $0.2B | $0.0B | $0.4B | $0.3B | $0.1B | $0.1B | $0.2B |
| Net Income | $-1.7B | $-0.0B | $1.1B | $0.3B | $0.2B | $0.0B | $-0.0B | $0.0B |
| EPS (Basic) | $-13.74 | $-0.13 | $8.77 | $2.17 | $1.52 | $0.38 | $-0.02 | $0.24 |
| EPS (Diluted) | $-13.74 | $-0.13 | $8.77 | $2.17 | $1.52 | $0.38 | $-0.02 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.7B | $11.7B | $11.9B | $11.2B | $10.6B | $10.2B | $9.9B | $10.0B |
| Current Assets | $5.0B | $5.0B | $5.1B | $5.4B | $4.9B | $4.4B | $4.1B | $4.0B |
| Cash & Equivalents | $0.6B | $0.4B | $0.3B | $0.6B | $0.5B | $0.6B | $0.3B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.8B | $3.0B | $3.4B | $3.8B | $3.5B | $2.8B | $2.7B | $3.0B |
| Stockholders' Equity | $2.1B | $4.5B | $4.4B | $3.4B | $3.0B | $3.0B | $2.5B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — | — | — | — |
| Investing Cash Flow | $-0.1B | $0.3B | — | — | — | — | — | — |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $0.4B | $-0.9B | $0.3B | $-0.2B | — | — | — | $-0.4B |